Decode Bio

Decode Bio is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Decode Bio develops a drug discovery platform that uses a novel encoding method to identify and validate drug targets more quickly and efficiently, aiming to reduce time and cost in drug discovery for pharmaceutical companies.